Renovorx Inc (RNXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RNXT | KALA | SABS | ||
| Company | Renovorx Inc | Kala Bio Inc | Sab Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1800 | 6.14 | 3.25 | ||
| High | 1.2727 | 6.55 | 3.25 | ||
| Low | 1.0800 | 6.10 | 2.95 | ||
| Last | 1.2101 | 6.55 | 3.07 | ||
| Change | +0.0201 | +0.12 | +0.01 | ||
| % Change | +1.69% | +1.87% | +0.33% | ||
| Volume | 115,300 | 23,700 | 27,100 | ||
| 20-Day Average Volume | 44,425 | 33,210 | 83,185 | ||
| Previous Close | 1.1900 | 6.43 | 3.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0681 | 6.90 | 3.35 | ||
| 20-Day Raw Stochastic | 83.20% | 29.73% | 26.55% | ||
| 20-Day Relative Strength | 62.88% | 51.97% | 49.28% | ||
| Weighted Alpha | -13.18 | -18.39 | -65.08 | ||
| Today's Opinion | 8% Buy | 8% Buy | 8% Buy | ||
| Previous Opinion | 8% Sell | 8% Buy | 8% Buy | ||
| Last Month's Opinion | 96% Sell | 64% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.02% since 11/14/24 | -3.11% since 11/14/24 | -17.03% since 11/14/24 | ||
| Low | 1.0400 on 11/19/24 | 6.00 on 11/20/24 | 2.95 on 11/21/24 | ||
| High | 1.2727 on 11/21/24 | 6.87 on 11/15/24 | 3.70 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +22.23% since 10/21/24 | +25.00% since 10/21/24 | +0.66% since 10/21/24 | ||
| Low | 0.7736 on 10/24/24 | 5.15 on 10/22/24 | 2.60 on 10/25/24 | ||
| High | 1.2727 on 11/21/24 | 7.85 on 11/11/24 | 4.37 on 11/04/24 | ||
| 3-Month | |||||
| %Chg | +14.17% since 08/21/24 | +8.99% since 08/21/24 | +13.70% since 08/21/24 | ||
| Low | 0.7736 on 10/24/24 | 4.95 on 10/17/24 | 2.36 on 10/15/24 | ||
| High | 1.3000 on 09/20/24 | 7.85 on 11/11/24 | 4.37 on 11/04/24 | ||
| 6-Month | |||||
| %Chg | -10.36% since 05/21/24 | -0.46% since 05/21/24 | +5.50% since 05/21/24 | ||
| Low | 0.7736 on 10/24/24 | 4.21 on 06/26/24 | 2.16 on 08/14/24 | ||
| High | 1.4100 on 06/18/24 | 7.88 on 07/15/24 | 4.37 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 29,044 | 30,196 | 28,334 | ||
| Shares Outstanding, K | 24,001 | 4,610 | 9,229 | ||
| Annual Sales | 0 | 0 | 2,240,000 | ||
| Annual Net Income | -10,230,000 | -42,200,000 | -42,190,000 | ||
| Last Quarter Sales | 0 | 0 | 260,000 | ||
| Last Quarter Net Income | -2,470,000 | -8,950,000 | -7,340,000 | ||
| 60-Month Beta | 0.99 | -2.13 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/24 | -1.93 on 11/12/24 | -1.12 on 11/06/24 | ||
| Latest Earnings Date | 11/11/24 | 11/11/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||